300 related articles for article (PubMed ID: 31927536)
1. Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1.
Cai LJ; Tu L; Li T; Yang XL; Ren YP; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian JY
Aging (Albany NY); 2020 Jan; 12(1):672-689. PubMed ID: 31927536
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway.
Cai L; Tu L; Li T; Yang X; Ren Y; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian J
Int Immunopharmacol; 2019 Oct; 75():105734. PubMed ID: 31301558
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
[TBL] [Abstract][Full Text] [Related]
4. Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson's disease via suppression of LASP1.
Ma X; Zhang H; Yin H; Geng S; Liu Y; Liu C; Zhao J; Liu Y; Wang X; Wang Y
Brain Res Bull; 2021 Jan; 166():92-101. PubMed ID: 33144090
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson's disease by upregulating microRNA-34b-5p and downregulating BACE1.
Li Y; Fang J; Zhou Z; Zhou Q; Sun S; Jin Z; Xi Z; Wei J
Cell Cycle; 2020 May; 19(10):1158-1171. PubMed ID: 32308102
[No Abstract] [Full Text] [Related]
6. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
[TBL] [Abstract][Full Text] [Related]
7. Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.
Liu YY; Zhang YN; Yang QS
J Cell Physiol; 2018 Nov; 233(11):8617-8629. PubMed ID: 29761857
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.
Choi DH; Cristóvão AC; Guhathakurta S; Lee J; Joh TH; Beal MF; Kim YS
Antioxid Redox Signal; 2012 May; 16(10):1033-45. PubMed ID: 22098189
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP
Yao L; Dai X; Sun Y; Wang Y; Yang Q; Chen X; Liu Y; Zhang L; Xie W; Liu J
J Neurosci Res; 2018 Oct; 96(10):1663-1676. PubMed ID: 30004136
[TBL] [Abstract][Full Text] [Related]
11. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
Li J; Wang LN; Xiao HL; Li X; Yang JJ
Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson's disease rats via regulation of TLR/NF-κB signaling pathway.
Ma X; Wang Y; Yin H; Hua L; Zhang X; Xiao J; Yuan Q; Wang S; Liu Y; Zhang S; Wang Y
Brain Res Bull; 2021 Sep; 174():22-30. PubMed ID: 33933526
[TBL] [Abstract][Full Text] [Related]
13. microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
Yao Y; Zhao Z; Zhang F; Miao N; Wang N; Xu X; Yang C
Brain Behav; 2023 Mar; 13(3):e2921. PubMed ID: 36795044
[TBL] [Abstract][Full Text] [Related]
14. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
Zhou S; Zhou X; Jiang Z; Ma J; Li Y; Qian Z; Li H
Neurochem Res; 2023 Mar; 48(3):942-955. PubMed ID: 36401052
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson's Disease.
Guo S; Gao Y; Zhao Y
ACS Chem Neurosci; 2023 Jun; 14(11):1981-1991. PubMed ID: 37166273
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-128 Protects Dopamine Neurons from Apoptosis and Upregulates the Expression of Excitatory Amino Acid Transporter 4 in Parkinson's Disease by Binding to AXIN1.
Zhou L; Yang L; Li YJ; Mei R; Yu HL; Gong Y; Du MY; Wang F
Cell Physiol Biochem; 2018; 51(5):2275-2289. PubMed ID: 30537735
[TBL] [Abstract][Full Text] [Related]
18. Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson's disease.
Jiang Y; Liu J; Chen L; Jin Y; Zhang G; Lin Z; Du S; Fu Z; Chen T; Qin Y; Sun X
Brain Res; 2019 Nov; 1722():146331. PubMed ID: 31301273
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
20. The interplay between neuroinflammatory pathways and Parkinson's disease.
Eser P; Kocabicak E; Bekar A; Temel Y
Exp Neurol; 2024 Feb; 372():114644. PubMed ID: 38061555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
